Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis

NCT02525523 is registered in ClinicalTrials.gov with Atlantic Pharmaceuticals Ltd as lead sponsor.

NCT NCT02525523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02525523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis
Lead sponsor
Atlantic Pharmaceuticals Ltd
Phase
Phase 3
Overall status
Completed
Start date
December 3, 2015
Completion date
October 29, 2018
Enrollment
138 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

pouchitis